Bajaj Healthcare · NSE: BAJAJHCARE · BSE: 539872
Q1 FY23 results · Apr–Jun 2022
Bajaj Healthcare reported revenue from operations of ₹172.07 crore (down 7.3% from Q1 FY22) and net profit of ₹12.02 crore (down 37.5% from Q1 FY22) for Q1 FY23 (Apr–Jun 2022), on a standalone basis.
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 172.07 | 185.69 | −7.3% | 175.71 | −2.1% |
| Other income | 0.67 | 0.68 | −1.4% | 0.45 | +49.5% |
| Total income | 172.74 | 186.37 | −7.3% | 176.16 | −1.9% |
| Profit before tax | 16.16 | 27.25 | −40.7% | 16.93 | −4.6% |
| Net profit for the period | 12.02 | 19.22 | −37.5% | 17.47 | −31.2% |
| EPS, basic (₹) | 4.35 | 13.93 | not comparable | 6.33 | −31.3% |
| Net margin (%) | 7.0 | 10.3 | 9.9 |
Standalone
- Filed with BSE
- 06 Sep 2022, 14:48 IST
- Board meeting
- 12 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE